Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial.
The Lancet. Infectious diseases（2023）
摘要
National Institute of Allergy and Infectious Diseases, bioMérieux.
更多查看译文
关键词
lower respiratory tract infections,lower procalcitonin,azithromycin,efficacy,placebo-controlled,double-blind,non-inferiority
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要